EP300 and cancer: The cancer cell proliferation was accompanied by significant inhibition of p300 histone acetyltransferase activity and p300-mediated NF-κB acetylation by melatonin, thereby blocking NF-κB binding and p300 recruitment to the COX-2 promoter [98].